Alzheimer's disease: Current therapy with cholinesterase inhibitors - Is it enzyme inhibition only?

被引:0
|
作者
Enz, A [1 ]
机构
[1] Novartis Pharma AG, Res Nervous Syst, Basel, Switzerland
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:178 / 178
页数:1
相关论文
共 50 条
  • [31] ADHERENCE TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH ALZHEIMER'S DISEASE
    Blais, Lucie
    Kettani, Fatima-Zohra
    Perreault, Sylvie
    Leroux, Jean-Christophe
    Forget, Amelie
    Kergoat, Marie-Jeanne
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (02) : 366 - 368
  • [32] Treatment of advanced Alzheimer's disease with cholinesterase inhibitors
    Korczyn, Amos D.
    ALZHEIMERS & DEMENTIA, 2008, 4 (05) : 371 - 372
  • [34] Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly
    Vandenberg, CM
    Kazmi, Y
    Jann, MW
    DRUGS & AGING, 2000, 16 (02) : 123 - 138
  • [35] Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
    Tayeb, Haythum O.
    Yang, Hyun Duk
    Price, Bruce H.
    Tarazi, Frank I.
    PHARMACOLOGY & THERAPEUTICS, 2012, 134 (01) : 8 - 25
  • [36] Comparison studies of cholinesterase inhibitors for Alzheimer's disease
    Hogan, DB
    Goldlist, B
    Naglie, G
    Patterson, C
    LANCET NEUROLOGY, 2004, 3 (10): : 622 - 626
  • [37] Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease in the Elderly
    Chad M. VanDen Berg
    Yusuf Kazmi
    Michael W. Jann
    Drugs & Aging, 2000, 16 : 123 - 138
  • [38] Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
    Sharma, JC
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (06) : 414 - 415
  • [39] Cholinesterase inhibitors in Alzheimer's disease - Are they worth the cost?
    Whitehouse, PJ
    CNS DRUGS, 1999, 11 (03) : 167 - 173
  • [40] PHARMACOLOGICAL RATIONALE FOR CHOLINESTERASE INHIBITION IN ALZHEIMER'S DISEASE
    Small, Gary
    NEUROBIOLOGY OF AGING, 2012, 33 : S32 - S32